Evidence map›Paper›PMID 37508176›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Evaluation of the One Health-Ness of 20 Years of Antimicrobial Resistance Surveillance in Norway.

Madelaine Norström, Gunnar Skov Simonsen, Jannice Schau Slettemeås, Anne-Sofie Furberg, Anne Margrete Urdahl

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Molecular epidemiology of methicillin-resistantFrontiers in microbiology · 2025
    Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Madelaine NorströmNorwegian Veterinary Institute, N-1431 Ås, Norway.
Gunnar Skov SimonsenDepartment of Microbiology and Infection Control, University Hospital of North Norway, N-9038 Tromsø, Norway.
Jannice Schau SlettemeåsNorwegian Veterinary Institute, N-1431 Ås, Norway.ORCID 0000-0003-2542-6991
Anne-Sofie FurbergDepartment of Microbiology and Infection Control, University Hospital of North Norway, N-9038 Tromsø, Norway.
Anne Margrete UrdahlNorwegian Veterinary Institute, N-1431 Ås, Norway.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We evaluated the One Health-ness (OH-ness) of the surveillance system for antimicrobial resistance (AMR) in Norway by using the recently developed "Evaluation tool for One Health epidemiological surveillance capacities and capabilities" (OH-EpiCap tool). First, we defined the Norwegian AMR surveillance system that we would evaluate. The tool was applied by a group of stakeholders (key persons in the Norwegian AMR surveillance programmes and authors of this paper). The evaluation was performed using a consensus approach. The evaluation resulted in an overall OH-ness score of 68% across all three dimensions included in the tool: Organisation, Operation, and Impact. Suggestions for improvement were only indicated within the areas of internal evaluation and operational costs, whereas most of the indicators included in the tool showed good adherence to the One Health principles. By performing this internal evaluation, we recognized that AMR surveillance in the environment needs to be included in a more systematic and standardized way to improve the OH-ness as defined by the quadripartite organisations. Last but not least, it was beneficial to bring key stakeholders together to conduct the evaluation. It increased a joint perception of the OH-ness of AMR surveillance in Norway and encouraged further collaboration in the future.

Indexed as

antimicrobial resistanceevaluationOH-EpiCapOne Healthsurveillance

Identifiers

PMID37508176
PMCPMC10376192

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.